Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptide
SPG20
Host: Synthetic
BP, Imm
-
- Target See all SPG20 products
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- EASGTDVKQL DQGNK
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Synonyms
- SPARTIN Peptide, TAHCCP1 Peptide, AI840044 Peptide, C79168 Peptide, mKIAA0610 Peptide, spartin Peptide, Spg20 Peptide, spg20a Peptide, zgc:172059 Peptide, spg20b Peptide, zgc:153766 Peptide, spartin Peptide, spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) Peptide, spartin a Peptide, spartin b Peptide, SPART Peptide, Spg20 Peptide, Spart Peptide, sparta Peptide, spartb Peptide
-
You are here:
